247 related articles for article (PubMed ID: 21397501)
1. Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
Komloova M; Musilek K; Horova A; Holas O; Dohnal V; Gunn-Moore F; Kuca K
Bioorg Med Chem Lett; 2011 Apr; 21(8):2505-9. PubMed ID: 21397501
[TBL] [Abstract][Full Text] [Related]
2. Preparation, in vitro evaluation and molecular modelling of pyridinium-quinolinium/isoquinolinium non-symmetrical bisquaternary cholinesterase inhibitors.
Komloova M; Horova A; Hrabinova M; Jun D; Dolezal M; Vinsova J; Kuca K; Musilek K
Bioorg Med Chem Lett; 2013 Dec; 23(24):6663-6. PubMed ID: 24220173
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatment.
Musilek K; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K
Eur J Med Chem; 2011 Feb; 46(2):811-8. PubMed ID: 21236521
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
Musilek K; Komloova M; Zavadova V; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K; Jung YS
Bioorg Med Chem Lett; 2010 Mar; 20(5):1763-6. PubMed ID: 20138518
[TBL] [Abstract][Full Text] [Related]
5. Preparation, in vitro screening and molecular modelling of monoquaternary compounds related to the selective acetylcholinesterase inhibitor BW284c51.
Benek O; Musilek K; Horova A; Dohnal V; Dolezal R; Kuca K
Med Chem; 2014; 11(1):21-9. PubMed ID: 24773345
[TBL] [Abstract][Full Text] [Related]
6. Does "butyrylization" of acetylcholinesterase through substitution of the six divergent aromatic amino acids in the active center gorge generate an enzyme mimic of butyrylcholinesterase?
Kaplan D; Ordentlich A; Barak D; Ariel N; Kronman C; Velan B; Shafferman A
Biochemistry; 2001 Jun; 40(25):7433-45. PubMed ID: 11412096
[TBL] [Abstract][Full Text] [Related]
7. The preparation, in vitro screening and molecular docking of symmetrical bisquaternary cholinesterase inhibitors containing a but-(2E)-en-1,4-diyl connecting linkage.
Musilek K; Pavlikova R; Marek J; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Dolezal M; Gunn-Moore F; Kuca K
J Enzyme Inhib Med Chem; 2011 Apr; 26(2):245-53. PubMed ID: 21406034
[TBL] [Abstract][Full Text] [Related]
8. Homo- and hetero-bivalent edrophonium-like ammonium salts as highly potent, dual binding site AChE inhibitors.
Leonetti F; Catto M; Nicolotti O; Pisani L; Cappa A; Stefanachi A; Carotti A
Bioorg Med Chem; 2008 Aug; 16(15):7450-6. PubMed ID: 18585045
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium-like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitors.
Pisani L; Catto M; Giangreco I; Leonetti F; Nicolotti O; Stefanachi A; Cellamare S; Carotti A
ChemMedChem; 2010 Sep; 5(9):1616-30. PubMed ID: 20677317
[TBL] [Abstract][Full Text] [Related]
10. [Acetylcholinesterase and butyrylcholinesterase in mouse skeletal muscle. Specificity of irreversible inhibition by an organophosphorus compound of the methylphosphorothiolate type and multiple molecular forms].
Goudou D; Friboulet A; Dreyfus P; Rieger F
C R Seances Acad Sci III; 1983 Jan; 296(4):169-72. PubMed ID: 6405980
[No Abstract] [Full Text] [Related]
11. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
Korabecny J; Musilek K; Holas O; Binder J; Zemek F; Marek J; Pohanka M; Opletalova V; Dohnal V; Kuca K
Bioorg Med Chem Lett; 2010 Oct; 20(20):6093-5. PubMed ID: 20817518
[TBL] [Abstract][Full Text] [Related]
12. Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis.
Harel M; Sussman JL; Krejci E; Bon S; Chanal P; Massoulié J; Silman I
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10827-31. PubMed ID: 1438284
[TBL] [Abstract][Full Text] [Related]
13. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
[TBL] [Abstract][Full Text] [Related]
14. Structure of a complex of the potent and specific inhibitor BW284C51 with Torpedo californica acetylcholinesterase.
Felder CE; Harel M; Silman I; Sussman JL
Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 2):1765-71. PubMed ID: 12351819
[TBL] [Abstract][Full Text] [Related]
15. Histochemical demonstration of acetylcholinesterase activity in human Meibomian glands.
Perra MT; Serra A; Sirigu P; Turno F
Eur J Histochem; 1996; 40(1):39-44. PubMed ID: 8741098
[TBL] [Abstract][Full Text] [Related]
16. Overlapping drug interaction sites of human butyrylcholinesterase dissected by site-directed mutagenesis.
Loewenstein-Lichtenstein Y; Glick D; Gluzman N; Sternfeld M; Zakut H; Soreq H
Mol Pharmacol; 1996 Dec; 50(6):1423-31. PubMed ID: 8967962
[TBL] [Abstract][Full Text] [Related]
17. Peripheral site acetylcholinesterase blockade induces RACK1-associated neuronal remodeling.
Farchi N; Ofek K; Podoly E; Dong H; Xiang YY; Diamant S; Livnah O; Li J; Hochner B; Lu WY; Soreq H
Neurodegener Dis; 2007; 4(2-3):171-84. PubMed ID: 17596712
[TBL] [Abstract][Full Text] [Related]
18. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
Di Pietro O; Viayna E; Vicente-García E; Bartolini M; Ramón R; Juárez-Jiménez J; Clos MV; Pérez B; Andrisano V; Luque FJ; Lavilla R; Muñoz-Torrero D
Eur J Med Chem; 2014 Feb; 73():141-52. PubMed ID: 24389509
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the nature of rat retinal acetylcholinesterase using a specific substrate and a specific inhibitor.
Sastry BV; Singh G; Loo P; Janson VE
J Ocul Pharmacol Ther; 1995; 11(3):401-9. PubMed ID: 8590272
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
